01
Cash & equivalents decreased 50.6%
Cash & equivalents changed -50.6% from the comparable as-filed period.
$75.9M→$37.5MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTOric Pharmaceuticals, Inc.'s latest supported as-filed period reports interest income of $1.7M. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -50.6% from the comparable as-filed period.
Net income changed -14.1% from the comparable as-filed period.
Operating income changed -16.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
ORIC · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-330631SEC ↗8-KAug 3, 2026Period Aug 3, 20260001193125-26-330568SEC ↗8-KJul 30, 2026Period Jul 28, 20260001193125-26-326309SEC ↗4Jul 28, 2026Period Jul 24, 20260001584759-26-000015SEC ↗4Jul 8, 2026Period Jul 6, 20260001584759-26-000012SEC ↗8-KJun 22, 2026Period Jun 18, 20260001193125-26-277511SEC ↗10-QMay 4, 2026Period Mar 31, 20260001193125-26-204047SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jul 24, 2026Filed Jul 28, 2026 | Heyman Richard A.Director | Option ExerciseDirect | 3,500 | $2 | $5,600 | Form 4 ↗ |
| Jul 24, 2026Filed Jul 28, 2026 | Heyman Richard A.Director | Open Market SaleDirect | 7,000 | $12 | $84,140 | Form 4 ↗ |
| Jul 24, 2026Filed Jul 28, 2026 | Heyman Richard A.Director | Open Market SaleIndirect | 6,100 | $12 | $73,322 | Form 4 ↗ |
| Jul 24, 2026Filed Jul 28, 2026 | Heyman Richard A.Director | Option ExerciseDirect | 3,500 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Stock-based compensation changed +7.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-203993